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Feasibility of an accurate assessment
of myocardial salvage by comparing functional
and perfusion abnormalities in post-reperfusion
gated SPECT
Roberto Sciagra`, MD,a Manjola Dona, MD,a Angela Coppola, MD,b
Mario Leoncini, MD,c Mauro Maioli, MD,c Antonio Castagnoli, MD,b
Francesco Bellandi, MD,c and Alberto Pupi, MDa
Background. Because of persistent stunning, post-treatment functional abnormalities
could identify the initial risk area. The study aims to detect myocardial salvage using post-
revascularization gated SPECT in acute myocardial infarction (AMI) treated by reperfusion
therapy.
Methods. In 36 AMI patients, we performed a first gated SPECT injecting 99mTc-sestamibi
before primary percutaneous coronary intervention (PCI), and a second 5 days later. The
salvage index defined by the two perfusion images was compared with the value obtained by
subtracting in the second gated SPECT the extent of perfusion defect from the extent of wall
thickening abnormalities.
Results. The wall thickening salvage index correlated with the reference perfusion salvage
index (Spearman’s q 5 .92, P < .0001), with a 95% limit of agreement 5 ±.25. The agreement
between the classifications in salvage index tertiles of the reference and of the wall thickening
salvage index was good (kappa 5 .75). All patients with optimal PCI result and 18/24 of those
with intermediate or poor outcome were correctly classified.
Conclusions. Comparing function and perfusion in a single post-PCI 99mTc-sestamibi gated
SPECT it is possible to estimate myocardial salvage. This could have useful implications in
studies comparing different treatment strategies for AMI. (J Nucl Cardiol 2010;17:825–30.)
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INTRODUCTION
The real success of reperfusion therapy in acute
myocardial infarction (AMI) is defined by the amount of
salvaged myocardium and this requires assessing both the
initial risk area and the ultimate myocardial damage.1-3
While the latter parameter can be easily evaluated using
various modalities (such as infarct size in perfusion or
magnetic resonance imaging), the measurement of the
former value is much more difficult, and is therefore
frequently omitted or replaced by indirect markers of
improvement achieved during treatment.4-7 However, the
assessment of myocardial salvage is of the utmost
importance, mainly in studies comparing different ther-
apeutic options for AMI. In particular, various studies
have proven the excellent capability of the salvage index
(the ratio of the degree of myocardial salvage to the initial
perfusion defect) to demonstrate in relatively small
patient populations which is the most effective alternative
between different AMI treatments, showing a close
relationship with the patient outcome.3,8-12 Therefore, a
readily feasible method that made possible a reliable
estimate of the initial risk area, and accordingly of the
salvage index, would be highly desirable and would have
major implications for the planning of clinical trials.
In a patient subgroup of the BRAVE-2 study, we
had explored the possibility to estimate the salvaged
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myocardium by comparing the extent of regional func-
tional abnormalities (that represent myocardial stunning)
and of perfusion defects (that indicate the residual
damage) in a perfusion gated single-photon emission
computed tomography (SPECT) with 99mTc-sestamibi
acquired few days after AMI.13 Although the results
appeared promising, that patient population was not rep-
resentative of the patients currently submitted to primary
percutaneous coronary intervention (PCI) for AMI,
because included patients only admitted very late after
symptom onset and who in part underwent just sponta-
neous reperfusion. Therefore, we performed the present
study to verify the accuracy of our approach in the correct
clinical setting of patients treated by primary PCI early
after AMI onset.
METHODS
Patient Population
We evaluated 36 consecutive patients with first AMI
referred to our catheterization laboratory for primary angio-
plasty within 6 hours of symptoms onset and who received
99mTc-sestamibi injection before mechanical recanalization.
AMI diagnosis was based on typical chest pain lasting for
[30 minutes associated with[.1 mV ST segment elevation in
at least two contiguous electrocardiographic leads. Exclusion
criteria were: (1) history of previous AMI or other heart dis-
ease; (2) presence of atrial fibrillation.
Study Protocol
At admission, all patients received aspirin, heparin,
clopidogrel, and abciximab (bolus of .25 mg/kg body weight
followed by a continuous infusion of .125 mcg/kg/minutes, up
to a maximum of 10 mcg/minutes, for 12 hours). Then,
patients were transferred to the catheterization laboratory
where 99mTc-sestamibi (740 MBq) was injected. Immediately
after tracer injection, patients underwent selective coronary
angiography and primary PCI. Admission gated SPECT was
acquired within 6 hours of tracer injection to assess the initial
perfusion defect (=risk area). Subsequently, patients underwent
a post-treatment resting gated SPECT at approximately 5 days
of index AMI to assess the changes in myocardial perfusion
defect and regional function. Finally, resting gated SPECT was
repeated at least one month after index infarction to assess the
left ventricular ejection fraction evolution. All patients gave
informed consent to participate in the study, which was
approved by the Ethics Committee of our institutions.
Coronary Angiography and Mechanical
Revascularization
Immediately after diagnostic angiography, PCI was per-
formed using standard material. The detection of TIMI grade 3
coronary flow in the treated vessel with a residual stenosis of
\20% was considered successful PCI.5
Gated SPECT
Scintigraphic images were acquired using a dual-head
gamma camera (ADAC Vertex, Milpitas, CA) equipped with
high-resolution collimators and with a 15% window centered
on the 140 keV photopeak of technetium-99m. SPECT was
performed in step-and-shoot mode, with 32 projections over a
180 elliptical orbit, matrix size 64 9 64, 45 second/projec-
tion, 8-frames/cardiac cycle. The studies were reconstructed
using filtered backprojection without attenuation or scatter
correction and realigned along the heart axis. The left ven-
tricular ejection fraction was calculated using the QGS
program.14
Data Analysis
For perfusion and function analysis, the left ventricular
polar map was divided into 17 segments. Regional myocardial
perfusion, and wall thickening were assessed visually by one
blinded experienced observer (M.D.), unaware of patient’s data
and image sequence, and they were scored using a 5-point scale
(0 = normal, 1 = mildly reduced, 2 = moderately reduced,
3 = severely reduced, 4 = absent uptake),15 and a 4-point scale
(0 = normal, 1 = mildly impaired, 2 = moderately impaired,
and 3 = severely impaired thickening), respectively.16 Previous
data indicate a good reproducibility of these visual estimates in
our laboratory.17
The segments with abnormal scores (scores 2-4 for per-
fusion and scores 1-3 for wall thickening)13 were identified and
the abnormalities were expressed as percent extent of the polar
maps. Therefore, the extent of any abnormality (perfusion or
wall thickening) was:
number of abnormal segments
17
 100
The salvaged myocardium was the difference between the
admission (=risk area) and the post-treatment perfusion
abnormality extent. The salvaged myocardium divided by the
initial risk area defined the salvage index. The reference
perfusion salvage index was compared with the wall thickening
salvage index. The wall thickening salvage index was: extent of
wall thickening abnormalities in post-treatment gated SPECT
minus perfusion defect extent in post-treatment gated SPECT
divided by extent of wall thickening anomalies in post-
treatment gated SPECT.13
Statistical Analysis
Continuous variables are expressed as mean ± standard
deviation or as median (25th to 75th percentile range), as
appropriate. The comparisons within groups were performed
with the Student t test for dependent samples or the Wilcoxon
matched-pairs signed-rank test, as appropriate. The correlation
between variables was assessed using the Spearman’s q. The
agreement between the different methods in establishing the
salvage index was assessed using the Bland-Altman analysis
and the kappa statistics. Linear regression analysis was used to
check the influence of the delay in post-treatment gated
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SPECT on the relationship between perfusion and wall thick-
ening salvage indexes and to establish the predictive value of
the salvage indexes for left ventricular ejection fraction evo-
lution. A P value\.05 was considered statistically significant.
RESULTS
The patient population included 28 men and 8
women. No patient had history of prior PCI and/or
coronary artery bypass grafting. As regards the infarct
location, 17 patients had anterior, 13 inferior, and 6
lateral infarction. Table 1 summarizes the main char-
acteristics of the patient population.
At admission, the extent of perfusion abnormalities
was 35% (24% to 47%). The post-treatment extent of
perfusion abnormalities was 15% (0% to 29%) (P \
.0001 vs admission). In the admission gated SPECT the
extent of wall thickening abnormalities was 47% (29%
to 69.5%) and in the post-treatment scan was 35% (24%
to 41%) (P \ .001 vs admission). This extent value was
not significantly different from the admission extent of
perfusion abnormalities. Moreover, there was a signifi-
cant correlation between post-treatment extent of wall
thickening abnormalities and admission extent of
abnormal perfusion (Spearman’s q = .78, P \ .0001).
The salvage index derived from percent extent of
perfusion defects was .49 (.26 to 1). The wall thickening
salvage index was .49 (.34 to 1) (NS vs perfusion salvage
index) and there was a close correlation between the two
values: Spearman’s q = .92 (P \ .0001) (Figure 1). As
shown in Figure 2, the Bland-Altman analysis demon-
strates that the 95% limit of agreement between
perfusion and wall thickening salvage indexes is ±.25.
According to univariate regression analysis with wall
thickening salvage index as dependent variable, the delay
of post-treatment gated SPECT included as covariate did
not influence the relationship between the perfusion
and the wall thickening salvage indexes (perfusion sal-
vage index F = 102.6, P \ .0001, post-treatment gated
SPECT delay F = .002, P = .97, model R2 = .98).
We compared the classification in salvage index
tertiles of the reference perfusion salvage index and of
the wall thickening salvage index. The agreement
between the classifications was very good, with
kappa = .75. In particular, all patients having a good
result according to the reference perfusion salvage index
were correctly classified by the wall thickening salvage
index. Among the patients with intermediate or poor
results according to reference perfusion salvage index,
one-fourth only (6/24) was misclassified by the wall
thickening salvage index, but the difference was always
of one grade only and was evenly distributed between
upgrading (3 cases) and underrating (3 cases).
In the one-month gated SPECT there was a left
ventricular ejection fraction increase as compared to
the admission value (51.9 ± 12.7% vs 38.6 ± 10.5%,
P \ .0001). According to linear regression analysis both
the perfusion salvage index and the wall thickening
Table 1. Clinical characteristics of the patient
population
Age (years, mean ± SD) 63.6 ± 10
Risk factors
Systemic arterial hypertension, n (%) 13 (36%)
Hypercholesterolemia (total
cholesterol[200 mg/dL), n (%)
16 (44%)
Diabetes mellitus, n (%) 7 (19%)
Smoking, n (%) 19 (53%)
Prior coronary artery by-pass grafting 0
Prior percutaneous coronary
intervention
0
Infarct related artery
Left anterior descending artery, n (%) 18 (50%)
Left circumflex artery, n (%) 4 (12%)
Right coronary artery, n (%) 14 (38%)
TIMI flow grade before PCI, median
(25th-75th percentile)
0 (0–1)
TIMI flow grade after PCI, median
(25th-75th percentile)
3 (3–3)
Symptoms to PCI delay, minutes
(mean ± SD)
205 ± 93
Peak CK, U/L (mean ± SD) 2704 ± 2130
Delay of post-treatment gated SPECT,
days, median (25th-75th percentile)
5 (4–6)
Figure 1. Correlation of wall thickening salvage index (x
axis) vs perfusion salvage index (y axis). The dashed line
represents the line of identity.
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salvage index were significant univariate predictors of
the left ventricular ejection fraction evolution: perfusion
salvage index F = 2.6, P \ .05, model R2 = .45, and
wall thickening salvage index F = 3.6, P \ .01, model
R2 = .61, respectively.
DISCUSSION
The present study confirms the findings of our
previous report in which we suggested that the extent of
the asynergic area in a delayed pre-discharge gated
SPECT could still be representative of the size of
myocardium at risk before reperfusion, according to the
model of myocardial stunning.13,18 The present results
show that with the wall thickening salvage index it is
possible to obtain a clinically acceptable estimate for the
true salvage index (with a 95% limit of agreement of
±.25 for a parameter ranging from 0 to 1), and a patient
classification in terms of good, intermediate, or poor
reperfusion success that is in good agreement with the
reference categorization (30/36 patient correctly classi-
fied). In agreement with prior reports on larger patient
populations,19 the perfusion salvage index predicts with
good accuracy the late left ventricular ejection fraction
evolution in the study cohort, and the wall thickening
salvage index appears to be equally effective in this
regard. These results have been obtained in a patient
population that is representative of the current candi-
dates to primary PCI, including patients who were all
treated within 6 hours of symptom onset. Moreover,
differently from our previous report, we achieved these
results using the presently recommended 17-segment
model for polar map evaluation.
We performed the post-treatment acquisition around
5 days after AMI. Myocardial stunning is a time-
dependent phenomenon and echocardiographic data
demonstrate that the first partial signs of regional func-
tional recovery can be registered within 48 hours of
AMI.20 For that reason, an early acquisition would
increase the extent of detectable stunning. On the other
hand, another study by the same group indicates that an
acquisition at 18-48 hours could overestimate the infarct
size as compared to a pre-discharge scan (i.e., at 6 to
14 days of AMI).21 Therefore, it is difficult to define the
optimal timing for gated SPECT. Our results were
achieved with a median delay that is intermediate
between the two above-mentioned time points. The
perfusion salvage index shows median value and inter-
quartile range that are comparable with those reported in
larger patient population using a longer delay (7 to
14 days).3,8-10 The same is true for the wall thickening
salvage index. Moreover, within our time range (2 to
Figure 2. Bland-Altman plot of agreement between the perfusion salvage index and the wall
thickening salvage index; the dashed lines represent the 95% limits of agreement.
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8 days), the post-treatment gated SPECT delay has no
influence on the relationship between perfusion and wall
thickening salvage indexes. These results would support
the proposition that gated SPECT should be acquired
few days after reperfusion (possibly later than 48 hours
and within one week of index infarction), taking into
account the patient’s clinical status.
Our findings are valuable because confirm the pos-
sibility to assess the salvage index after primary PCI
using a single gated SPECT performed in the first days
after reperfusion. This is important in the single patient’s
evaluation, because it allows identifying the initial area
at risk, a parameter that is otherwise very difficult to
define without the complicated logistics of a radionuclide
tracer injection before acute coronary intervention.22
However, the possibility to classify the reperfusion
results not just in terms of residual damage, but in terms
of actual myocardial salvage is far more essential for
comparative studies about different therapeutic strategies
for AMI, because it could potentially reduce the sample
size needed to recognize the treatment effectiveness.
Presently, the use of infarct size as surrogate end-point
does not allow directly differentiating a small infarction
obtained by extensive myocardial salvage from an ini-
tially limited risk area without major treatment effects.
On the other hand, the adjunct of indirect indicators of
reperfusion success that may partly overcome the infarct
size limitations requires more complex protocols and
introduces additional sources or errors. Although there
are no doubts that alternative imaging modalities could
be helpful, at present the wide availability and extensive
experience of perfusion gated SPECT represent a clear
advantage of our proposed approach.23-25
Some limitations of the present study must be con-
sidered. The patient population is small, as in most
studies that require pre-reperfusion tracer injection.
There were no patients with prior infarction and it is
reasonable to assume that in those patients the reliability
of our approach (as that of the infarct size measurement)
would be poor because of the possible interference of the
asynergic area caused by the old necrosis. The criteria
used to compare perfusion and functional data by trans-
lating the related scores in extent of abnormalities on the
polar maps remain arbitrary. However, the good results
obtained in a different patient population reinforce their
reliability. It is reasonable to assume that the automatic
definition of abnormalities in percent of left ventricle that
is offered by various processing algorithms for gated
SPECT could improve the reliability and reproducibility
of our method. Finally, this approach is based on the
detection of prolonged stunning, and therefore might be
less reliable in small infarctions, where tethering from
adjacent normal tissue could interfere with the recogni-
tion of wall motion abnormalities.
In conclusion, this study confirms that by compar-
ing the extent of wall thickening and perfusion
abnormalities in a single post-treatment gated SPECT it
is possible to easily achieve a reliable assessment of the
salvage index in AMI patients treated by primary PCI.
References
1. Gibbons MK, Mahmarian JJ, Chesebro JH, Wackers FJ. Feasi-
bility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-
isonitrile imaging for the assessment of myocardial area at risk and
the effect of treatment in acute myocardial infarction. Circulation
1989;80:1277-85.
2. Santoro GM, Bisi G, Sciagra` R, Leoncini M, Fazzini PF,
Meldolesi U. Single photon emission tomography with techne-
tium-99m hexakis 2-methoxyisobutyl isonitrile in acute
myocardial infarction before and after thrombolytic treatment:
Assessment of salvaged myocardium and prediction of late func-
tional recovery. J Am Coll Cardiol 1990;150:301-14.
3. Scho¨mig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U,
Pache J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa
blockade compared with tissue plasminogen activator in acute
myocardial infarction. Stent versus Thrombolysis for Occluded
Coronary Arteries in Patients with Acute Myocardial Infarction
Study Investigators. N Engl J Med 2000;343:385-91.
4. Santoro GM, Antoniucci D, Valenti R, Bolognese L, Buonamici P,
Trapani M, et al. Rapid reduction of ST-segment elevation after
successful direct angioplasty in acute myocardial infarction. Am J
Cardiol 1997;80:685-9.
5. Poli A, Fetiveau R, Vandoni P, del Rosso G, D’Urbano M, Seveso
G, et al. Integrated analysis of myocardial blush and ST-segment
elevation recovery after successful primary angioplasty. Real-time
grading of microvascular reperfusion and prediction of early and
late recovery of left ventricular function. Circulation 2002;106:
313-8.
6. van’t Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ,
Zijlstra F. Angiographic assessment of myocardial reperfusion in
patients treated with primary angioplasty for acute myocardial
infarction: Myocardial blush grade. Zwolle Myocardial Infarction
Study Group. Circulation 1998;97:2302-6.
7. Gibbons RJ, Miller TD, Christian TF. Infarct size measured by
single photon emission computed tomographic imaging with
(99m)Tc-sestamibi: A measure of the efficacy of therapy in acute
myocardial infarction. Circulation 2000;101:101-8.
8. Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache
J, et al. Stent versus Thrombolysis for Occluded Coronary Arteries
in Patients With Acute Myocardial Infarction (STOPAMI-2)
Study. Myocardial salvage after coronary stenting plus abciximab
versus fibrinolysis plus abciximab in patients with acute myocar-
dial infarction: A randomised trial. Lancet 2002;359:920-5.
9. Kastrati A, Mehilli J, Nekolla S, Bollwein H, Martinoff S, Pache J.
STOPAMI-3 Study Investigators. A randomized trial comparing
myocardial salvage achieved by coronary stenting versus balloon
angioplasty in patients with acute myocardial infarction consid-
ered ineligible for reperfusion therapy. J Am Coll Cardiol 2004;
43:734-41.
10. Ndrepepa G, Mehilli J, Schwaiger M, Schu¨hlen H, Nekolla S,
Martinoff S, et al. Prognostic value of myocardial salvage
achieved by reperfusion therapy in patients with acute myocardial
infarction. J Nucl Med 2004;45:725-9.
11. Parodi G, Ndrepepa G, Kastrati A, Conti A, Mehilli J, Sciagra` R,
et al. Beyond 12 hours Reperfusion AlternatiVe Evaluation
Journal of Nuclear Cardiology Sciagra` et al 829
Volume 17, Number 5;825–30 Gated SPECT salvage index
(BRAVE-2) Trial Investigators. Ability of mechanical reperfusion
to salvage myocardium in patients with acute myocardial infarc-
tion presenting beyond 12 hours after onset of symptoms. Am
Heart J 2006;152:1133-9.
12. Busk M, Kaltoft A, Nielsen SS, Bøttcher M, Rehling M, Thuesen
L, et al. Infarct size and myocardial salvage after primary angio-
plasty in patients presenting with symptoms for\12 h vs. 12-72 h.
Eur Heart J 2009;30:1322-30.
13. Sotgia B, Sciagra` R, Parodi G, Kastrati A, Antoniucci D, Scho¨mig
A, et al. Estimate of myocardial salvage in late presentation acute
myocardial infarction by comparing functional and perfusion
abnormalities in predischarge gated SPECT. Eur J Nucl Med Mol
Imaging 2008;35:906-11.
14. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su
HT, et al. Automatic quantification of ejection fraction from gated
myocardial perfusion SPECT. J Nucl Med 1995;36:2138-47.
15. Sharir T, Germano G, Waechter PB, Kavanagh PB, Areeda JS,
Gerlach J, et al. A new algorithm for the quantitation of myo-
cardial perfusion SPECT. II: Validation and diagnostic yield.
J Nucl Med 2000;41:720-7.
16. Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS. Auto-
matic quantitation of regional myocardial wall motion and
thickening from gated technetium-99m sestamibi myocardial
perfusion single-photon emission computed tomography. J Am
Coll Cardiol 1997;30:1360-7.
17. Leoncini M, Marcucci G, Sciagra` R, Frascarelli F, Traini AM,
Mondanelli D, et al. Nitrate-enhanced gated technetium 99m
sestamibi SPECT for evaluating regional wall motion at baseline
and during low-dose dobutamine infusion in patients with chronic
coronary artery disease and left ventricular dysfunction: Com-
parison with two-dimensional echocardiography. J Nucl Cardiol
2000;7:426-31.
18. Braunwald E, Kloner RA. The stunned myocardium: Prolonged,
postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
19. Ndrepepa G, Mehilli J, Martinoff S, Schwaiger M, Scho¨mig A,
Kastrati A. Evolution of left ventricular ejection fraction and its
relationship to infarct size after acute myocardial infarction. J Am
Coll Cardiol 2007;50:149-56.
20. Oh JK, Gibbons RJ, Christian TF, Gersh BJ, Click RL, Sitthisook
S, et al. Correlation of regional wall motion abnormalities detected
by two-dimensional echocardiography with perfusion defect
determined by technetium 99m sestamibi imaging in patients
treated with reperfusion therapy during acute myocardial infarc-
tion. Am Heart J 1996;131:32-7.
21. Pellikka PA, Behrenbeck T, Verani MS, Mahmarian JJ, Wackers
FJT, Gibbons RJ. Serial changes in myocardial per fusion using
tomographic technetium 99m-hexakis-2-methoxy-2-methylpropyl-
isonitrile imaging following reperfusion therapy of myocardial
infarction. J Nucl Med 1990;31:1269-75.
22. Pennell D. Myocardial salvage: Retrospection, resolution, and
radio waves. Circulation 2006;113:1821-3.
23. Sciagra` R, Leoncini M. Gated single-photon emission computed
tomography. The present-day ‘‘one-stop-shop’’ for cardiac imag-
ing. Q J Nucl Med Mol Imaging 2005;49:19-29.
24. Main ML, Magalski A, Chee NK, Coen MM, Skolnick DG, Good
TH. Full-motion pulse inversion power Doppler contrast echo-
cardiography differentiates stunning from necrosis and predicts
recovery of left ventricular function after acute myocardial
infarction. J Am Coll Cardiol 2001;38:1390-4.
25. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt
RF Jr, et al. Retrospective determination of the area at risk for
reperfused acute myocardial infarction with T2-weighted cardiac
magnetic resonance imaging: Histopathological and displacement
encoding with stimulated echoes (DENSE) functional validations.
Circulation 2006;113:1865-70.
830 Sciagra` et al Journal of Nuclear Cardiology
Gated SPECT salvage index September/October 2010
